31st Mar 2020 14:18
(Sharecast News) - The Science Group said it was in talks to make 10,000 ventilators for the UK government after coming up with a prototype in less than three weeks.
Read more3rd Mar 2020 15:12
(Sharecast News) - Science Group reported organic business performance in line with its upgraded expectations in its full-year results on Tuesday, with group revenue rising to £57.25m for 2019, from £48.67m.
Read more15th Oct 2019 11:27
(Sharecast News) - Science Group announced on Tuesday that its statutory merger with Frontier Smart Technologies Group had become effective on 11 October.
Read more14th Dec 2018 08:14
(Sharecast News) - Science Group terminated its formal sale process on Friday, citing uncertainties related to the UK's exit from the EU.
Read more7th Dec 2016 07:07
(ShareCast News) - Accounting software company Sage confirmed it was considering selling its North American payments business, after it had reported flat revenue growth in the year. The FTSE 100 company said it is "evaluating potential strategic options" for the payments business in North America, i
Read more16th Sep 2016 10:05
(ShareCast News) - Science Group announced a new 10-year, £15m loan facility on Friday, as the board worked to shore up its finances. The AIM-traded firm said that following the 2015 acquisitions and the purchase of the additional freehold property at Great Burgh, Epsom, the board has been reviewing
Read more11th Jul 2016 14:57
(ShareCast News) - Sagent Pharmaceuticals was up 40% in pre-market trading after agreeing a deal with Japanese firm Nichi-Iko Pharmaceutical. Deal amounts to $736mn in cash for Sagent as both boards back the transactionThe acquisition will allow Nichi-Iko to expand its operations in the United State
Read more24th Jul 2014 08:59
Afren: JP Morgan shifts target price from 180p to 188p upgrading from underweight to overweight. Anglo American: Jefferies raises target price from 1550p to 1700p and reiterates a hold recommendation. Antofagasta: Jefferies increases target price from 825p to 1000p upgrading from hold to buy. ARM
Read more5th Mar 2014 10:02
Abcam: Investec reduces target price from 552p to 480p and reiterates its buy recommendation. Numis upgrades from hold to buy with a target price 510p. Advanced Medical Solutions: Canaccord Genuity shifts target price from 94p to 101p and keeps a hold recommendation. African Barrick Gold: Nomura r
Read more27th Jan 2014 09:49
Sagentia, the technology and product development services company, announced on Monday the appointment of a new Finance Director. Rebecca Hempsted was appointed Finance Director and was to replace Neil Elton, with effect from today. Hempsted, who is a chartered accountant and has a physics degree
Read more9th Jul 2013 07:53
Adept Telecom: Northland Capital revises target price from 108p to 115p and maintains a buy recommendation. AG Barr: Panmure Gordon raises target price from 500p to 600p and retains a hold recommendation. Aquarius Platinum: Westhouse Securities shifts target price from 35p to 40p upgrading from se
Read more3rd Jun 2013 07:22
Anglo Pacific Group: Finncap cuts target price from 320p to 279p staying with its buy recommendation. Ashtead Group: Citi takes target price from 660p to 750p and maintains a buy recommendation. Centrica: Berenberg ups target price from 370p to 380p keeping a hold recommendation. Coal of Afica: I
Read more22nd Apr 2013 07:20
Admiral Group: Deutsche Bank takes target price from 1140p to 1300p retaining a hold recommendation. African Barrick Gold: Deutsche Bank ups target price from 173p to 180p staying with its hold recommendation. Albemarle & Bond: Canaccord Genuity reduces target price from 280p to 146p and downgrade
Read more4th Mar 2013 07:12
Aggreko: JP Morgan takes target price from 1845p to 1870p, while reiterating a neutral rating. Anglo American: Nomura reduces target price from 1800p to 1700p and downgrades from neutral to reduce. ARM Holdings: Deutsche Bank increases target price from 400p to 445p, but still recommends selling.
Read more16th Apr 2012 10:28
The research and development consultancy, Sagentia, has issued a warning on 2012 revenues after a big project with a north American medical start-up was suspended. Sagentia says the suspension will see revenues in the first half of 2012 coming in lower than the second six months of 2011. The group
Read more